share_log

Morgan Stanley Raises Price Target on Silence Therapeutics to $49 From $45, Keeps Overweight Rating

Morgan Stanley Raises Price Target on Silence Therapeutics to $49 From $45, Keeps Overweight Rating

大摩资源lof将沉默治疗的目标股价从45美元上调至49美元,保持超配评级。
MT Newswires ·  06/28 06:16

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发